21 U.S.C. § 360e
Premarket approval
United States · Title 21 — FOOD AND DRUGS · Status: effective
Cite this
- Citation
- 21 U.S.C. § 360e, Premarket approval, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/454272
- Permanent ID
ys:prov:454272@1- SHA-256
89eafcbe8cbe9852097fea720489130374c2d1582100d3a68d2fd1162df6c6bb
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
A class III device—
In the case of a class III device which—
A proposed order required under paragraph (1) shall contain—
Any person may file with the Secretary an application for premarket approval for a class III device. Such an application for a device shall contain—
Any person may file with the Secretary a report seeking premarket approval for a class III device referred to in subsection (a) that is a reprocessed single-use device. Such a report shall contain the following:
In the case of a class III device referred to in subsection (a) that is a reprocessed single-use device:
Upon receipt of an application meeting the requirements set forth in paragraph (1), the Secretary—
As promptly as possible, but in no event later than one hundred and eighty days after the receipt of an application under subsection (c) (except as provided in section 360j(l)(3)(D)(ii) of this title or unless, in accordance with subparagraph (B)(i), an additional period as agreed upon by the Secretary and the applicant), the Secretary, after considering the report and recommendation submitted under paragraph (2) of such subsection, shall—
The Secretary shall accept and review statistically valid and reliable data and any other information from investigations conducted under the authority of regulations required by section 360j(g) of this title to make a determination of whether there is a reasonable assurance of safety and effectiveness of a device subject to a pending application under this section if—
The Secretary shall deny approval of an application for a device if, upon the basis of the information submitted to the Secretary as part of the application and any other information before him with respect to such device, the Secretary finds that—
The Secretary shall notify the applicant promptly of—
Subject to clause (ii), in reviewing a supplement to an approved application, for an incremental change to the design of a device that affects safety or effectiveness, the Secretary shall approve such supplement if—
The Secretary shall, upon obtaining, where appropriate, advice on scientific matters from a panel or panels under section 360c of this title, and after due notice and opportunity for informal hearing to the holder of an approved application for a device, issue an order withdrawing approval of the application if the Secretary finds—
Any person may submit to the Secretary a proposed product development protocol with respect to a device. Such a protocol shall be accompanied by data supporting it. If, within thirty days of the receipt of such a protocol, the Secretary determines that it appears to be appropriate to apply the requirements of this subsection to the device with respect to which the protocol is submitted, the Secretary—
A proposed product development protocol for a device may be approved only if—
the Secretary determines that the proposed protocol provides—
At any time after a product development protocol for a device has been approved pursuant to paragraph (4), the person for whom the protocol was approved may submit a notice of completion—
The Secretary may, after providing the person who has an approved protocol an opportunity for an informal hearing and at any time prior to receipt of notice of completion of such protocol, issue a final order to revoke such protocol if he finds that—
After the receipt of a notice of completion of an approved protocol the Secretary shall, within the ninety-day period beginning on the date such notice is received, by order either declare the protocol completed or declare it not completed. An order declaring a protocol not completed may take effect only after the Secretary has provided the person who has the protocol opportunity for an informal hearing on the order. Such an order may be issued only if the Secretary finds—
Upon petition for review of—
Upon petition for review of—
Orders of the Secretary under this section shall be served (1) in person by any officer or employee of the department designated by the Secretary, or (2) by mailing the order by registered mail or certified mail addressed to the applicant at his last known address in the records of the Secretary.
After the issuance of an order under paragraph (1) but before the date that is 2 years after July 9, 2012, the Secretary shall issue an administrative order following publication of a proposed order in the Federal Register, a meeting of a device classification panel described in section 360c(b) of this title, and consideration of comments from all affected stakeholders, including patients, payors, and providers, notwithstanding subchapter II of chapter 5 of title 5, for each device—
Legislative history
The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.
- Medical Device Amendments of 1976House: no recorded tallySenate: no recorded tally
- Safe Medical Devices Act of 1990House: no recorded tallySenate: no recorded tally
- Nutrition Labeling and Education Act Amendments of 1993House: no recorded tallySenate: no recorded tally
- Food and Drug Administration Modernization Act of 1997House: no recorded tallySenate: 98–2
- Medical Device User Fee and Modernization Act of 2002House: no recorded tallySenate: no recorded tally
- Medical Devices Technical Corrections ActHouse: 396–0Senate: no recorded tally
- Food and Drug Administration Amendments Act of 2007House: 405–7Senate: no recorded tally
- Food and Drug Administration Safety and Innovation ActHouse: no recorded tallySenate: 96–1
- 21st Century Cures ActHouse: no recorded tallySenate: no recorded tally
- FDA Reauthorization Act of 2017House: no recorded tallySenate: 94–1
- Consolidated Appropriations Act, 2023House: 225–201Senate: no recorded tally